Skip to main content

Parliamentary debates and questions

S5W-17584: Miles Briggs (Lothian)

Scottish Conservative and Unionist Party

Date lodged: 3 July 2018

To ask the Scottish Government, further to the answer to question S5W-08991 by Shona Robison on 9 May 2017, whether it will provide an update on any plans to introduce antiobiotic tests in the NHS.

Answered by: Jeane Freeman 20 July 2018

An Evidence Review was published by Healthcare Improvement Scotland on 8 May 2018 which looked at the cost-effectiveness of C-reactive protein testing in primary care. National and international studies were reviewed and it was concluded that, while published evidence is available, it is not strong enough to support widespread adoption of C-reactive protein testing.

Regarding other tests, Procalcitonin is used mainly in intensive care units and trials are on-going in other settings. It is an expensive and non-specific test with conflicting evidence as to its usefulness.

In relation to fungal infections, The Scottish Antimicrobial Prescribing Group has requested a cost-effectiveness analysis of biomarker tests to inform antifungal treatment in Critical Care and Haemato-oncology which is expected to be completed in late 2018 or early 2019.

The Evidence Review was published at:

http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/shtg_-_evidence_notes/evidence_note_80.aspx .